Regulation of glucose transport in human skeletal muscle

Annals of Medicine

Volumn 34, Issue 6, 2002, Pages 410-418

  Koistinen, H A ^a,b   Zierath, Juleen R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

AMPK; Exercise; Glucose transport; Insulin resistance; Insulin signalling; Obesity

Indexed keywords

GLUCOSE TRANSPORTER 1; INSULIN;

DIABETES MELLITUS; ENVIRONMENTAL FACTOR; EXERCISE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEREDITY; HUMAN; INSULIN RESISTANCE; MUSCLE CONTRACTION; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 0036914753     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/078538902321012351     Document Type: Review

References (80)

1. Kahn CR. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes 1994; 43: 1066-84.
2. DeFronzo RA. The Triumvirate: β-cell, muscle or liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-87.
3. Vaag A, Henriksen JE, Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 782-8.
4. DeFronzo RA, Jocot E, Jequier E, Maeder E, Wahren J, Felber JP. The effect of insulin on the disposal of intravenous glucose. Diabetes 1981; 30: 1000-7.
5. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J Clin Invest 1985; 76: 149-55.
6. Eriksson J, Koranyi L, Bourey R, Schalin C, Widén E, Mueckler M et al. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 1992; 35: 143-7.
7. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-8.
8. Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, et al. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 1196-204.
9. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 1999; 341: 240-6.
10. Dohm GL, Tapscott EB, Pories WJ, Dabbs DJ, Flickinger EG, Meelheim D, et al. An in vitro human skeletal muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest 1988; 82: 486-94.
11. Zierath JR, Galuska D, Engström Å, Johnson KH, Betsholtz C, Westermark P, et al. Human islet amyloid polypeptide at pharmacological levels inhibit insulin and phorbol ester-stimulated glucose transport in in vitro incubated human skeletal muscle strips. Diabetologia 1992; 35: 26-31.
12. Andréasson K, Galuska D, Thörne A, Sonnenfeld T, Wallberg-Henriksson H. Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type 11 diabetic subjects. Acta Physiol Scand 1991; 142: 255-60.
13. Krook A, Björnholm M, Galuska D, Jiang X-J, Fahlman R, Myers Jr. MG, et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 284-92.
14. Friedman JE, Ishizuka T, Shao J, Huston L, Highman T, Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48: 1807-14.
15. Kasuga M, Hedo JA, Yamada KM, Kahn CR. Structure of insulin receptor and its subunits. J Biol Chem 1982; 257: 10392-9.
16. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73-7.
17. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr. MG, Glasheen E, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995; 377: 173-7.
18. Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 11439-43.
19. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 1997; 272: 21403-7.
20. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb-2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996; 379: 560-4.
21. Ribon V, Saltiel AR. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem J 1997; 324: 839-45.
22. White MF. The insulin signalling system: A network of docking proteins that mediate insulin action. Mol Cell Biochem 1998; 182: 3-11.
23. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 1995; 92: 5817-21.
24. Shepherd PR, Nave BT, Rincon J, Haigh RJ, Foulstone E, Proud C, et al. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: Implications for glucose metabolism. Diabetologia 1997; 40: 1172-7.
25. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PRJ, Reese CB, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr Biol 1997; 7: 261-9.
26. Nakanishi H, Brewer KA, Exton JH. Activation of the ζ isoenzyme of protein kinase C by phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 1993; 268: 13-6.
27. Bandyopadhyay G, Standaert ML, Zhao L, Yu B, Avignon A, Galloway L, et al. Activation of Protein Kinase C (α, β, and ζ) by insulin in 3T3/L1 cells: Transfection studies suggest a role for PKC-ζ in glucose transport. J Biol Chem 1997; 272: 2551-8.
28. Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Quon MJ, Lea-Currie R, et al. PKC-ζ mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J Clin Endocrinol Metab 2002; 87: 716-23.
29. Krook A, Whitehead JP, Dobson SP, Griffiths MR, Ouwens M, Baker C, et al. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphatidylinositol 3-kinase activation alone is not sufficient for the meditation of insulin's metabolic and mitogenic effects. J Biol Chem 1997; 272: 30208-14.
30. Jiang T, Sweeney G, Rudolf MT, Klip A, Traynor-Kaplan A, Tsien RY. Membrane-permeant esters of phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 1998; 273: 11017-24.
31. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407: 147-8.
32. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 410: 944-8.
33. Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991; 40: 815-9.
34. Klein HH, Vestergaard H, Kotzke G, Pedersen O. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Diabetes 1995; 44: 1310-7.
35. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000; 10: 311-20.
36. Arner P, Pollare T, Lithell H, Livingston JN. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 437-40.
37. Nolan JJ, Freidenberg G, Henery R, Reichart D, Olefsky JM. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 1994; 78: 471-7.
38. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin dependent diabetes. J Clin Invest 1987; 79: 1330-7.
39. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195-204.
40. Shao J, Yamashita H, Qiao L, Draznin B, Friedman JE. Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes 2002; 51: 19-29.
41. Björnholm M, Kawano Y, Lehtihet M, Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in skeletal muscle from NIDDM subjects following in vivo insulin stimulation. Diabetes 1997; 46: 524-7.
42. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 1999; 104: 733-41.
43. Krook A, Roth RA, Jiang XJ, Zierath JR, Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from non-insulin-dependent diabetic subjects. Diabetes 1998; 47: 1281-6.
44. Vollenweider P, Menard B, Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (ζ/λ) activation in myotubes from obese patients with impaired glucose tolerance Diabetes 2002; 51: 1052-9.
45. Douen AG, Ramlal T, Rastogi SA, Bilan PJ, Cartee GD, Vranic M, et al. Exercise induces recruitment of the "insulin responsive" glucose transporter. Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 1990; 265: 13427-30.
46. Hirshman MF, Goodyear LJ, Wardzala LJ, Horton ED, Horton ES. Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem 1990; 265: 987-91.
47. Dohm G, Elton C, Friedman J, Pilch PF, Pories W, Atkinson S, et al. Decreased expression of glucose transporters in muscle from insulin-resistant patients. Am J Physiol Endocrinol Metab 1991; 260: E459-63.
48. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J. Expression of insulin-regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990; 33: 625-7.
49. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 39: 865-70.
50. Gumà A, Zierath JR, Wallberg-Henriksson H, Klip A. Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am J Physiol Endocrinol Metab 1995; 268: E613-22.
51. Zierath JR, He L, Guma A, Wahlström E, Klip A, Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996; 39: 1180-9.
52. Holman GD, Kozka IJ, Clark AE, Flower CJ, Saltis J, Habberfield AD, et al. Cell-surface labeling of glucose transporter isoform GLUT4 by Bis-Mannose photolabel: Correlation with stimulation of glucose transport in rat adipose cells by insulin and phorbol ester. J Biol Chem 1990; 265: 18172-9.
53. Koumanov F, Yang J, Jones AE, Hatanaka Y, Holman GD. Cell-surface biotinylation of GLUT4 using bis-mannose photolabels. Biochem J 1998; 330: 1209-15.
54. Lund S, Holman GD, Zierath JR, Rincon J, Nolte LA, Clark AE, et al. Effect of insulin on GLUT4 translocation and turnover rate in human skeletal muscle as measured by the exofacial bismannose photolabeling technique. Diabetes 1997; 46: 1965-9.
55. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR. Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle: Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 2000; 275: 1457-62.
56. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991; 70: 1593-600.
57. Zierath JR, Tsao T-S, Stenbit AE, Ryder JW, Galuska D, Charron MJ. Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 1998; 273: 20910-5.
58. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48: 1192-7.
59. Zierath JR. In vitro studies of human skeletal muscle. Hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 1995; 155(Suppl. 626): 1-96.
60. Wallberg-Henriksson H, Constable SH, Young DA, Holloszy JO. Glucose transport into rat skeletal muscle: Interaction between exercise and insulin. J Appl Physiol 1988; 65: 909-13.
61. Ryder JW, Yang J, Galuska D, Rincón J, Björnholm M, Krook A, et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-54.
62. Koistinen HA, Galuska D, Chibalin A, Holman GD, Wallberg-Henriksson H, Zierath JR. AICAR increases glucose transport in isolated skeletal muscle from non-diabetic and type 2 diabetic men. Diabetes 2002; 51: A310.
63. Brozinick Jr. JT, Birnbaum MJ. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem 1998; 273: 14679-82.
64. Lund S, Pryor PR, Ostergaard S, Schmitz O, Pedersen O, Holman GD. Evidence against protein kinase B as a mediator of contraction-induced glucose transport and GLUT4 translocation in rat skeletal muscle. FEBS Letters 1998; 425: 472-4.
65. Widegren U, Jiang XJ, Krook A, Chibalin AV, Björnholm M, Tally M, et al. Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. FASEB J 1998; 12: 1379-89.
66. Goodyear JJ, Giorgino F, Balon TW, Condorelli G, Smith RJ. Effects of contractile activity on tyrosine phosphorylation and PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 1995; 268: E987-95.
67. Hayashi T, Hirshman MF, Kuth EJ, Winder WW, Goodyear LJ. Evidence for 5′-AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47: 1369-73.
68. Youn JH, Gulve EA, Holloszy JO. Calcium stimulates glucose transport in skeletal muscle by a pathway independent of contraction. Am J Physiol Cell Physiol 1991; 260: C555-61.
69. Youn JH, Gulve EA, Henriksen EJ, Holloszy JO. Interactions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 1994; 267: R888-94.
70. Mu J, Brozinick JTJ, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001; 7: 1085-94.
71. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 1998; 17: 1688-99.
72. Song X, Fiedler M, Galuska D, Ryder JW, Fernström M, Chibalin AV, et al. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice. Diabetologia 2002; 45: 56-65.
73. Musi N, Fujii N, Hirshman MF, Ekberg I, Fröberg S, Ljungqvist O et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with Type 2 diabetes during exercise. Diabetes 2001; 50: 921-7.
74. Rodgers MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, Holloszy JO. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 1988; 11: 613-8.
75. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd PR, et al. Exercise increases muscle GLUT4-levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol Endocrinol Metab 1993; 264: E855-62.
76. Houmard JA, Egan PC, Neufer PD, Friedman JE, Wheeler WS, Israel RG, et al. Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol Endocrinol Metab 1991; 261: E437-43.
77. Hjeltnes N, Galuska D, Björnholm M, Aksnes A-K, Lannem A, Zierath JR, et al. Exercise-induced overexpression of key regulatory proteins involved in glucose uptake and metabolism in tetraplegic persons: Molecular mechanism for improved glucose homeostasis. FASEB J 1998; 12: 1701-12.
78. Dela F, Handberg A, Mikines KJ, Vinten J, Galbo H. GLUT4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol 1993; 469: 615-24.
79. Yu M, Blomstrand E, Chibalin AV, Krook A, Zierath JR. Marathon running increases ERK1/2 and p38 MAP Kinase signalling to downstream targets in human skeletal muscle. J Physiol 2001; 536: 273-82.
80. Chibalin AV, Yu M, Ryder JW, Song XM, Galuska D, Krook A, et al. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: Differential effects on insulin receptor substrates 1 and 2. Proc Natl Acad Sci USA 2000; 97: 38-43.